MAX vs REGN
MediaAlpha Inc. (MAX) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
MediaAlpha Inc. (MAX) is a internet content & information company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MAX revenue for 2024-12-31 was $864.7M. Net income was $22.1M. Revenue was up 122.8% from 2023-12-31 to 2024-12-31. MAX currently screens at market cap $689.0M and trailing P/E 36.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MAX currently screens at market cap $689.0M and trailing P/E 36.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MAX and REGN stock pages for the full models.
Not investment advice.